Astrana Health Gross Profit Growth & History (ASTH)
Astrana Health's gross profit was $341.5M for fiscal 2025.
View full Astrana Health company overviewAstrana Health annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $341.5M | $70.1M | +25.85% |
| 2024 | 2024-12-31 | $271.4M | $56.4M | +26.25% |
| 2023 | 2023-12-31 | $215.0M | $15.5M | +7.76% |
| 2022 | 2022-12-31 | $199.5M | $21.7M | +12.21% |
| 2021 | 2021-12-31 | $177.8M | $29.8M | +20.14% |
| 2020 | 2020-12-31 | $148.0M | $55.2M | +59.43% |
| 2019 | 2019-12-31 | $92.8M | −$66.0M | −41.54% |
| 2018 | 2018-12-31 | $158.8M | $75.9M | +91.52% |
| 2017 · Dec 31 | 2017-12-31 | $82.9M | $31.7M | +62.04% |
| 2017 · Mar 31 | 2017-03-31 | $8.7M | −$1.4M | −13.49% |
| 2016 · Dec 31 | 2016-12-31 | $51.2M | — | — |
| 2016 · Mar 31 | 2016-03-31 | $10.0M | −$874,367 | −8.01% |
| 2015 | 2015-03-31 | $10.9M | — | — |
| 2013 | 2014-01-31 | $1.4M | −$51,875 | −3.55% |
| 2012 | 2013-01-31 | $1.5M | $481,560 | +49.22% |
| 2011 | 2012-01-31 | $978,407 | $396,545 | +68.15% |
| 2010 | 2011-01-31 | $581,862 | — | — |
Astrana Health quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $104.0M | $26.1M | +33.41% |
| Q1 2026 | 2026-03-31 | $105.7M | $34.4M | +48.25% |
| Q4 2025 | 2025-12-31 | $95.0M | $44.6M | +88.28% |
| Q3 2025 | 2025-09-30 | $97.2M | $23.7M | +32.25% |
| Q2 2025 | 2025-06-30 | $78.0M | $4.5M | +6.14% |
| Q1 2025 | 2025-03-31 | $71.3M | −$2.6M | −3.55% |
| Q4 2024 | 2024-12-31 | $50.5M | $11.5M | +29.50% |
| Q3 2024 | 2024-09-30 | $73.5M | $694,000 | +0.95% |
| Q2 2024 | 2024-06-30 | $73.5M | $18.1M | +32.76% |
| Q1 2024 | 2024-03-31 | $74.0M | $26.1M | +54.57% |
| Q4 2023 | 2023-12-31 | $39.0M | −$2.1M | −5.14% |
| Q3 2023 | 2023-09-30 | $72.8M | −$3.4M | −4.51% |
| Q2 2023 | 2023-06-30 | $55.3M | $15.7M | +39.63% |
| Q1 2023 | 2023-03-31 | $47.8M | $5.3M | +12.51% |
| Q4 2022 | 2022-12-31 | $41.1M | $17.8M | +76.63% |
| Q3 2022 | 2022-09-30 | $76.2M | −$3.4M | −4.28% |
| Q2 2022 | 2022-06-30 | $39.6M | $203,000 | +0.51% |
| Q1 2022 | 2022-03-31 | $42.5M | $7.1M | +19.99% |
| Q4 2021 | 2021-12-31 | $23.3M | −$16.4M | −41.37% |
| Q3 2021 | 2021-09-30 | $79.6M | $21.3M | +36.61% |
| Q2 2021 | 2021-06-30 | $39.4M | $10.3M | +35.52% |
| Q1 2021 | 2021-03-31 | $35.4M | $14.5M | +69.57% |
| Q4 2020 | 2020-12-31 | $39.7M | $12.8M | +47.66% |
| Q3 2020 | 2020-09-30 | $58.3M | $33.4M | +133.85% |
| Q2 2020 | 2020-06-30 | $29.1M | $403,000 | +1.40% |
| Q1 2020 | 2020-03-31 | $20.9M | $8.6M | +69.58% |
| Q4 2019 | 2019-12-31 | $26.9M | $824,997 | +3.17% |
| Q3 2019 | 2019-09-30 | $24.9M | −$45.5M | −64.62% |
| Q2 2019 | 2019-06-30 | $28.7M | $5.7M | +24.94% |
| Q1 2019 | 2019-03-31 | $12.3M | −$27.0M | −68.65% |
| Q4 2018 | 2018-12-31 | $26.0M | $13.9M | +114.59% |
| Q3 2018 | 2018-09-30 | $70.5M | $40.1M | +131.80% |
| Q2 2018 · Jun 30 | 2018-06-30 | $23.0M | $8.3M | +56.84% |
| Q1 2018 · Mar 31 | 2018-03-31 | $39.3M | $13.6M | +52.78% |
| Q4 2017 | 2017-12-31 | $12.1M | $9.2M | +310.18% |
| Q2 2018 · Sep 30 | 2017-09-30 | $30.4M | $27.9M | +1139.96% |
| Q1 2018 · Jun 30 | 2017-06-30 | $14.6M | $12.4M | +553.94% |
| Q4 2017 | 2017-03-31 | $25.7M | $23.6M | +1119.30% |
| Q4 2016 | 2016-12-31 | $3.0M | $762,845 | +34.74% |
| Q2 2017 | 2016-09-30 | $2.5M | −$653,945 | −21.06% |
| Q1 2017 | 2016-06-30 | $2.2M | −$397,589 | −15.08% |
| Q4 2016 | 2016-03-31 | $2.1M | −$921,784 | −30.40% |
| Q3 2016 | 2015-12-31 | $2.2M | $644,038 | +41.49% |
| Q2 2016 | 2015-09-30 | $3.1M | −$2.4M | −43.58% |
| Q1 2016 | 2015-06-30 | $2.6M | $1.8M | +215.85% |
| Q4 2015 | 2015-03-31 | $3.0M | — | — |
| Q3 2015 · Dec 31 | 2014-12-31 | $1.6M | $750,819 | +93.70% |
| Q3 2014 | 2014-09-30 | $5.5M | $5.2M | +1988.86% |
| Q2 2014 | 2014-06-30 | $834,647 | $677,883 | +432.42% |
| Q3 2015 · Dec 31 | 2013-12-31 | $801,310 | — | — |
| Q3 2013 · Oct 31 | 2013-10-31 | $464,616 | $298,420 | +179.56% |
| Q3 2013 · Sep 30 | 2013-09-30 | $263,476 | — | — |
| Q2 2013 · Jul 31 | 2013-07-31 | $226,653 | −$217,125 | −48.93% |
| Q2 2013 · Jun 30 | 2013-06-30 | $156,764 | — | — |
| Q1 2013 | 2013-04-30 | $586,073 | $282,888 | +93.31% |
| Q4 2012 | 2013-01-31 | $546,808 | $149,809 | +37.74% |
| Q3 2012 | 2012-10-31 | $166,196 | −$168,637 | −50.36% |
| Q2 2012 | 2012-07-31 | $443,778 | $289,407 | +187.47% |
| Q1 2012 | 2012-04-30 | $303,185 | $210,981 | +228.82% |
| Q4 2011 | 2012-01-31 | $396,999 | — | — |
| Q3 2011 | 2011-10-31 | $334,833 | $183,874 | +121.80% |
| Q2 2011 | 2011-07-31 | $154,371 | −$20,605 | −11.78% |
| Q1 2011 | 2011-04-30 | $92,204 | — | — |
| Q3 2010 | 2010-10-31 | $150,959 | — | — |
| Q2 2010 | 2010-07-31 | $174,976 | — | — |
Astrana Health gross profit trends
Over the last five fiscal years, Astrana Health's gross profit increased from $148.0M to $341.5M, a change of $193.6M. The latest reported quarter, Q2 2026, shows $104.0M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Astrana Health source filings ↗